ArticleMolecular pharmaceutics2017

Rational Targeting of Cellular Cholesterol in Diffuse Large B-Cell Lymphoma (DLBCL) Enabled by Functional Lipoprotein Nanoparticles: A Therapeutic Strategy Dependent on Cell of Origin.

Jonathan S Rink et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.